This test is most useful if any of these apply to you.
The wall of your small intestine is about one cell thick. That thin lining decides what gets into your blood and what stays in your gut. When it loosens, partly digested food, bacterial fragments, and inflammatory chemicals slip through. The downstream symptoms can show up almost anywhere: bloating, hives, headaches, joint pain, foggy thinking, autoimmune flares.
Most testing for gut problems looks at what is living inside your gut. This panel looks at the gut wall itself, plus what is already crossing it. It uses four different signals to triangulate the same question: is the barrier doing its job?
This panel is research-oriented. Major medical societies do not yet recommend any of these markers as a standardized barrier workup, and lab-to-lab reference ranges still vary. Treat the results as a structured hypothesis about what might be happening, not as a diagnosis. The patterns are most useful when they map onto symptoms you are already experiencing.
The panel covers three connected ideas about gut barrier function: the gatekeeper protein that opens and closes the junctions between gut cells, evidence that bacterial outer membrane fragments are crossing into circulation, and the body's ability to clear an inflammatory molecule that floods in when the barrier is loose.
Tight-junction signaling. Zonulin is the only known human protein that reversibly loosens the seams between intestinal cells. Antibodies against zonulin (the IgG, IgA, and IgM versions) suggest the immune system has been seeing zonulin chronically, which has been linked in human studies to celiac disease, type 1 diabetes, non-alcoholic fatty liver disease, obesity-associated insulin resistance, and inflammatory bowel disease.
Bacterial translocation. LPS (lipopolysaccharide) is the outer coat of gram-negative gut bacteria. When the barrier loosens, LPS pieces cross into blood and the immune system makes antibodies against them. Elevated anti-LPS IgA and IgM have been documented in human studies of chronic fatigue syndrome and chronic depression, and circulating LPS has been linked to obesity, type 2 diabetes, and cardiovascular disease.
Histamine handling. Histamine is the chemical behind many allergy-like symptoms: flushing, itching, hives, headaches, racing heart after meals, loose stools. Diamine oxidase (DAO) is the enzyme that breaks histamine down at the gut wall. If histamine is high and DAO is low, the body is being flooded faster than it can clear. The DAO-to-histamine ratio captures that balance in one number.
Single markers in this panel are easy to misread. The combinations are what carry information. A few patterns to look for:
| Pattern | What It Suggests |
|---|---|
| High Zonulin antibodies, high LPS antibodies | Active barrier disruption with bacterial fragments reaching circulation. Often seen alongside autoimmune or metabolic conditions. |
| High histamine, low DAO, low DAO:Histamine ratio | Histamine intolerance pattern. Symptoms after fermented foods, alcohol, aged cheese, or leftovers are clues. |
| Normal Zonulin and LPS antibodies, low DAO | Histamine clearance problem without strong evidence of barrier breach. Diet and DAO cofactors (copper, B6) become the focus. |
| Everything elevated | Generalized gut-immune activation. Worth pairing with a microbiome or stool panel to find the upstream driver. |
Reference ranges vary by lab. Anchor your interpretation to your symptoms and your own baseline rather than to a single cutoff.
All five markers can swing for reasons unrelated to chronic barrier dysfunction. Recent infection, a course of NSAIDs, alcohol the night before, or intense endurance exercise can transiently raise zonulin and LPS signals. A histamine-heavy meal within hours of the draw can push histamine up artificially. Pregnancy raises DAO sharply because the placenta produces it, which makes the ratio uninterpretable in that window.
Commercial zonulin assays have been criticized in published research for poor correlation with the lactulose-to-mannitol permeability test that has traditionally served as the reference. Take a high or low zonulin antibody result as a signal to investigate further, not as a stand-alone diagnosis.
If the panel points to active barrier disruption (elevated zonulin and LPS antibodies), the next layer of testing is the gut content itself: a stool-based microbiome panel to look for dysbiosis, and a celiac screen if it has not been done. If the symptoms include joint pain or new autoimmune features, a basic autoimmune workup is worth adding.
If the panel points to a histamine-handling problem (low DAO, high histamine, low ratio), the most productive next step is a structured low-histamine trial of two to four weeks, ideally with a clinician, while looking at copper, B6, and gut inflammation as potential drivers of low DAO. Triggers to track during the trial include alcohol, aged cheese, cured meats, fermented foods, leftovers, and tomatoes.
Retest after a meaningful intervention, not before. For gut barrier work, three to six months is enough time for tight-junction protein turnover and immune signaling to shift. Repeating sooner mostly captures noise.
Advanced Intestinal Barrier Assessment is best interpreted alongside these tests.